Home›Companies›Healthcare›Alps Dx

Alps DX, Inc.

Alps Dx makes equipment and software for laboratories preparing oral fluid drug tests.

Updated Nov 10, 2026·Latest SEC filing Jul 7, 2026·Suggest an edit

About Alps Dx

Alps Dx is a private company based in Richmond, Virginia, incorporated in 2024 in Virginia. It has reported $1,600,000 raised in two offerings on Form D since July 2025. Its chief executive is Ali Safavi.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 30, 2026Jul 7, 2026$700,000of $3.2M target5$140KEquityRule 506(b)Form D ↗
Jun 23, 2025Jul 3, 2025$900,000of $1.2M target5$180KEquityRule 506(b)Form D ↗
Total, two offerings$1,600,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Alps Dx's Form D filed Jul 7, 2026.

Leslie Edinboro
Leslie Edinboro
Chief Science Officer, Co-founder
Ali Safavi
Ali Safavi
President, Chief Executive Officer, Co-founder

Sources

  1. SECALPS DX, Inc. filing history
  2. CompanyTerms and Conditions
  3. CompanyAbout Us
  4. CompanyMeet Our Team
  5. CompanyAlps Dx and Hamilton Company Announcement